BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 19635106)

  • 61. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.
    Stacchiotti S; Pedeutour F; Negri T; Conca E; Marrari A; Palassini E; Collini P; Keslair F; Morosi C; Gronchi A; Pilotti S; Casali PG
    Int J Cancer; 2011 Oct; 129(7):1761-72. PubMed ID: 21128251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22).
    Craver R; Dewenter T; Ebran N; Pedeutour F
    Cancer Genet Cytogenet; 2006 Jul; 168(2):155-7. PubMed ID: 16843106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Abbott JJ; Erickson-Johnson M; Wang X; Nascimento AG; Oliveira AM
    Mod Pathol; 2006 Nov; 19(11):1512-8. PubMed ID: 16980946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.
    Llombart B; Serra-Guillén C; Rubio L; Nagore E; Requena C; Traves V; Calomarde L; Bancalari B; López-Guerrero JA; Guillen-Barona C; Sanmartín O
    J Am Acad Dermatol; 2017 Sep; 77(3):503-511.e1. PubMed ID: 28420485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medallion-like dermal dendrocyte hamartoma: the main diagnostic pitfall is congenital atrophic dermatofibrosarcoma.
    Marque M; Bessis D; Pedeutour F; Viseux V; Guillot B; Fraitag-Spinner S
    Br J Dermatol; 2009 Jan; 160(1):190-3. PubMed ID: 19016705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dermatofibrosarcoma protuberans of breast.
    Sandberg AA; Anderson WD; Fredenberg C; Hashimoto H
    Cancer Genet Cytogenet; 2003 Apr; 142(1):56-9. PubMed ID: 12660034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cryptic COL1A1-PDGFB fusion in dermatofibrosarcoma protuberans: a clinicopathological and genetic analysis].
    Chen M; Chen YM; Lu Y; He X; Peng H; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):13-18. PubMed ID: 36617900
    [No Abstract]   [Full Text] [Related]  

  • 68. Atrophic dermatofibrosarcoma protuberans: report of a case demonstrated by detecting COL1A1-PDGFB rearrangement.
    Qiao J; Patel KU; López-Terrada D; Fang H
    Diagn Pathol; 2012 Nov; 7():166. PubMed ID: 23199263
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.
    Han A; Chen EH; Niedt G; Sherman W; Ratner D
    Arch Dermatol; 2009 Jul; 145(7):792-6. PubMed ID: 19620561
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atrophic dermatofibrosarcoma protuberans with the fusion gene COL1A1-PDGFB detected by RT-PCR using only a single primer pair.
    Xu WJ; Wang JS
    Int J Clin Exp Pathol; 2015; 8(6):7457-63. PubMed ID: 26261653
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dermatofibrosarcoma protuberans is CD117 negative even after extreme antigen retrieval conditions.
    Fernandez-Flores A
    Rom J Morphol Embryol; 2007; 48(4):419-21. PubMed ID: 18060194
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.
    Greco A; Fusetti L; Villa R; Sozzi G; Minoletti F; Mauri P; Pierotti MA
    Oncogene; 1998 Sep; 17(10):1313-9. PubMed ID: 9771975
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Dermatofibrosarcoma protuberans].
    Sanmartín O; Llombart B; López-Guerrero JA; Serra C; Requena C; Guillén C
    Actas Dermosifiliogr; 2007 Mar; 98(2):77-87. PubMed ID: 17397592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
    Gooskens SL; Oranje AP; van Adrichem LN; de Waard-van der Spek FB; den Hollander JC; van de Ven CP; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Aug; 55(2):369-73. PubMed ID: 20582941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
    Kasper B; Lossignol D; Gil T; Flamen P; De Saint Aubain N; Awada A
    Anticancer Drugs; 2006 Nov; 17(10):1223-5. PubMed ID: 17075323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dermatofibrosarcoma protuberans with COL1A1-PDGFB fusion transcript arising on a scar due to a previous drainage tube insertion.
    Saeki H; Kadono T; Le Pavoux A; Mori E; Tamaki K
    J Dermatol; 2008 Oct; 35(10):686-8. PubMed ID: 19017053
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery.
    Wright TI; Petersen JE
    Dermatol Surg; 2007 Jun; 33(6):741-4. PubMed ID: 17550456
    [No Abstract]   [Full Text] [Related]  

  • 78. [Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate].
    Zhu JH; Li QW; Xiao WH; Sun JZ; Wang RL; Lu JY
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):470-2. PubMed ID: 21875491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene copy number changes in dermatofibrosarcoma protuberans - a fine-resolution study using array comparative genomic hybridization.
    Kaur S; Vauhkonen H; Böhling T; Mertens F; Mandahl N; Knuutila S
    Cytogenet Genome Res; 2006; 115(3-4):283-8. PubMed ID: 17124411
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.
    Thomison J; McCarter M; McClain D; Golitz LE; Goldenberg G
    J Cutan Pathol; 2008 Nov; 35(11):1003-6. PubMed ID: 18544062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.